These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

869 related items for PubMed ID: 19013353

  • 21. Acinetobacter baumannii bloodstream infection while receiving tigecycline: a cautionary report.
    Peleg AY, Potoski BA, Rea R, Adams J, Sethi J, Capitano B, Husain S, Kwak EJ, Bhat SV, Paterson DL.
    J Antimicrob Chemother; 2007 Jan; 59(1):128-31. PubMed ID: 17082201
    [Abstract] [Full Text] [Related]

  • 22. Antimicrobial susceptibility of extended-spectrum beta-lactamase producers and multidrug-resistant Acinetobacter baumannii throughout the United States and comparative in vitro activity of tigecycline, a new glycylcycline antimicrobial.
    Hoban DJ, Bouchillon SK, Dowzicky MJ.
    Diagn Microbiol Infect Dis; 2007 Apr; 57(4):423-8. PubMed ID: 17403448
    [Abstract] [Full Text] [Related]

  • 23. In vitro activities of non-traditional antimicrobials alone or in combination against multidrug-resistant strains of Pseudomonas aeruginosa and Acinetobacter baumannii isolated from intensive care units.
    Timurkaynak F, Can F, Azap OK, Demirbilek M, Arslan H, Karaman SO.
    Int J Antimicrob Agents; 2006 Mar; 27(3):224-8. PubMed ID: 16464562
    [Abstract] [Full Text] [Related]

  • 24. In vitro activity of tigecycline as a therapeutic option against multidrug-resistant Acinetobacter spp.
    Eser OK, Ergin A, Tunçkanat F, Hasçelik G.
    New Microbiol; 2008 Oct; 31(4):535-42. PubMed ID: 19123310
    [Abstract] [Full Text] [Related]

  • 25. Prevalence of multidrug-resistant bacteria at a tertiary-care teaching hospital in Mexico: special focus on Acinetobacter baumannii.
    Garza-González E, Llaca-Díaz JM, Bosques-Padilla FJ, González GM.
    Chemotherapy; 2010 Oct; 56(4):275-9. PubMed ID: 20693798
    [Abstract] [Full Text] [Related]

  • 26. Mutant prevention concentration of tigecycline for carbapenem-susceptible and -resistant Acinetobacter baumannii.
    Cui JC, Liu YN, Chen LA.
    J Antibiot (Tokyo); 2010 Jan; 63(1):29-31. PubMed ID: 19911030
    [No Abstract] [Full Text] [Related]

  • 27. Comparative assessment of antimicrobial susceptibility testing for tigecycline and colistin against Acinetobacter baumannii clinical isolates, including multidrug-resistant isolates.
    Piewngam P, Kiratisin P.
    Int J Antimicrob Agents; 2014 Nov; 44(5):396-401. PubMed ID: 25442358
    [Abstract] [Full Text] [Related]

  • 28. In vitro activity of tigecycline against Acinetobacter baumannii isolates from a teaching hospital in Malaysia.
    Dhabaan GN, AbuBakar S, Shorman MA, Hassan H.
    J Chemother; 2012 Apr; 24(2):87-92. PubMed ID: 22546763
    [Abstract] [Full Text] [Related]

  • 29. Early experience with tigecycline for ventilator-associated pneumonia and bacteremia caused by multidrug-resistant Acinetobacter baumannii.
    Schafer JJ, Goff DA, Stevenson KB, Mangino JE.
    Pharmacotherapy; 2007 Jul; 27(7):980-7. PubMed ID: 17594203
    [Abstract] [Full Text] [Related]

  • 30. AdeABC multidrug efflux pump is associated with decreased susceptibility to tigecycline in Acinetobacter calcoaceticus-Acinetobacter baumannii complex.
    Ruzin A, Keeney D, Bradford PA.
    J Antimicrob Chemother; 2007 May; 59(5):1001-4. PubMed ID: 17363424
    [Abstract] [Full Text] [Related]

  • 31. Postantibiotic effects of tigecycline, colistin sulfate, and levofloxacin alone or tigecycline-colistin sulfate and tigecycline-levofloxacin combinations against Acinetobacter baumannii.
    Ozbek B, Sentürk A.
    Chemotherapy; 2010 May; 56(6):466-71. PubMed ID: 21088399
    [Abstract] [Full Text] [Related]

  • 32. In vitro effect of minocycline and colistin combinations on imipenem-resistant Acinetobacter baumannii clinical isolates.
    Tan TY, Ng LS, Tan E, Huang G.
    J Antimicrob Chemother; 2007 Aug; 60(2):421-3. PubMed ID: 17540671
    [Abstract] [Full Text] [Related]

  • 33. In vitro activity of tigecycline against carbapenemase-producing Acinetobacter baumannii.
    Hawser SP, Hackel M, Person MB, Higgins PG, Seifert H, Dowzicky M.
    Int J Antimicrob Agents; 2010 Sep; 36(3):289-90. PubMed ID: 20558046
    [No Abstract] [Full Text] [Related]

  • 34. In vitro effects of tigecycline in combination with colistin (polymyxin E) and sulbactam against multidrug-resistant Acinetobacter baumannii.
    Ni W, Cui J, Liang B, Cai Y, Bai N, Cai X, Wang R.
    J Antibiot (Tokyo); 2013 Dec; 66(12):705-8. PubMed ID: 23981963
    [Abstract] [Full Text] [Related]

  • 35. Influence of testing methodology on the tigecycline activity profile against presumably tigecycline-non-susceptible Acinetobacter spp.
    Casal M, Rodríguez F, Johnson B, Garduno E, Tubau F, de Lejarazu RO, Tenorio A, Giménez MJ, Bartolomé R, Garcia-Rey C, Aguilar L, García-Escribano N.
    J Antimicrob Chemother; 2009 Jul; 64(1):69-72. PubMed ID: 19451133
    [Abstract] [Full Text] [Related]

  • 36. Antimicrobial susceptibility of tigecycline and comparators against bacterial isolates collected as part of the TEST study in Europe (2004-2007).
    Nørskov-Lauritsen N, Marchandin H, Dowzicky MJ.
    Int J Antimicrob Agents; 2009 Aug; 34(2):121-30. PubMed ID: 19342205
    [Abstract] [Full Text] [Related]

  • 37. Pharmacodynamic evaluation of tigecycline against Acinetobacter baumannii in a murine pneumonia model.
    Koomanachai P, Kim A, Nicolau DP.
    J Antimicrob Chemother; 2009 May; 63(5):982-7. PubMed ID: 19279050
    [Abstract] [Full Text] [Related]

  • 38. Nationwide surveillance in Taiwan of the in-vitro activity of tigecycline against clinical isolates of extended-spectrum beta-lactamase-producing Enterobacteriaceae.
    Lu CT, Chuang YC, Sun W, Liu YC, Cheng YJ, Lu PL, Chen CM, Hsu GJ, Jang TN, Lee CM, Chiang PC, Shi ZY, Wang LS, Kung HC, Lin HC, Liao CH, Liu JW, Huang CH, Tsao SM, Hsueh PR.
    Int J Antimicrob Agents; 2008 Nov; 32 Suppl 3():S179-83. PubMed ID: 19013351
    [Abstract] [Full Text] [Related]

  • 39. Unexpected tigecycline resistance among Acinetobacter baumannii Isolates: high minor error rate by Etest.
    Kulah C, Celebi G, Aktas E, Mengeloglu Z, Comert F, Ankarali H.
    J Chemother; 2009 Aug; 21(4):390-5. PubMed ID: 19622456
    [Abstract] [Full Text] [Related]

  • 40. In vitro activity of tigecycline in combination with cefoperazone-sulbactam against multidrug-resistant Acinetobacter baumannii.
    Liu B, Bai Y, Liu Y, Di X, Zhang X, Wang R, Wang J.
    J Chemother; 2015 Oct; 27(5):271-6. PubMed ID: 25068186
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 44.